Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System
Authors
Campos, Monica Rodrigues.Schramm, Joyce Mendes de Andrade
Martins Emmerick, Isabel Cristina
Rodrigues, Jessica Muzy
Genovez de Avelar, Fernando
Pimentel, Thiago Goes
UMass Chan Affiliations
Department of SurgeryDocument Type
Journal ArticlePublication Date
2020-10-30Keywords
Coronavirus InfectionsCOVID-19
Potential Years of Life Lost
Indicator of Morbidity and Mortality
Primary Health Care
Epidemiology
Infectious Disease
International Public Health
Virus Diseases
Metadata
Show full item recordAbstract
COVID-19 is an acute infectious respiratory distress syndrome (ARDS) caused by the novel coronavirus SARS-CoV-2. The disease is highly communicable and produces mild to severe symptoms, generating a high demand for intensive care and thousands of deaths. In March 2020, COVID-19 was declared a pandemic and has already surpassed five million cases and 300,000 deaths in the world. The natural history of the disease has still not been fully established, hindering the elaboration of effective clinical protocols and preventive measures. Nevertheless, the disease requires a systemic approach, since there is evidence of acute and chronic complications, in addition to the catastrophic effects on the population's mental health. This highlights the need for a methodology that more effectively captures the effect of COVID-19, considering such aspects as severity, duration, and the potential to generate chronic complications that will increase the demands on Brazilian Unified National Health System (SUS). DALYs, or disability-adjusted life years, are thus an extremely useful indictor that adds mortality, an estimate of years of life lost (YLLs), and morbidity, an estimate of years of life lived with disability (YLDs). This article discusses the relevance and difficulties of studying the burden of COVID-19 and its complications in the Brazilian context, highlighting the natural history of the disease and estimating indicators such as YLDs, considering the high burden of disease in planning strategies to deal with the consequences of COVID-19 after the pandemic. The article also discusses the future challenges to deal with the disease in the SUS and the effects on the calculation of DALYs.Source
Campos MR, Schramm JMA, Emmerick ICM, Rodrigues JM, Avelar FG, Pimentel TG. Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System. Cad Saude Publica. 2020 Oct 30;36(11):e00148920. English, Portuguese. doi: 10.1590/0102-311X00148920. PMID: 33146278. Link to article on publisher's site
DOI
10.1590/0102-311X00148920Permanent Link to this Item
http://hdl.handle.net/20.500.14038/41604PubMed ID
33146278Related Resources
Rights
This article is published in Open Access under the Creative Commons Attribution license, which allows use, distribution, and reproduction in any medium, without restrictions, as long as the original work is correctly cited.Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1590/0102-311X00148920
Scopus Count
Except where otherwise noted, this item's license is described as This article is published in Open Access under the Creative Commons Attribution license, which allows use, distribution, and reproduction in any medium, without restrictions, as long as the original work is correctly cited.